Evaluate

Do you need to break through the limitations of conventional forecasting in your R&D and M&A activities? Download our complimentary #eBook and discover how #EvaluateOmnium can help ow.ly/ymFm50LUzPR

With all the hype around #AI and #DataScience in the #Pharma industry, it can be difficult to see past the shiny promises to business benefits. Our complimentary #whitepaper offers a practical view of embedding data science into your workflow. Learn more ow.ly/PaKe50LJ47J

Did you know that with #AI-powered tools, you could pinpoint the most promising drug candidates for in-licencing or #acquisition? Learn more in our free #whitepaper here ow.ly/UVVv50LJ466

Download our latest #eBook to learn more about the impact of #covid on drug green lights and a potential end-of-year boost to drug approvals from the #FDA. Will the end of the year be less of a damp squib? Find out in our download here ow.ly/ZPmW50LM4Xa

Using #AI & #MachineLearning can could help differentiate between a successful deal from an expensive flop. Download our #whitepaper to learn more ow.ly/8UEl50LJ3F2

In our complimentary #whitepaper, learn how #Omnium applies #MachineLearning to millions of data points across the full #clinical pipeline to power better R&D and more. Download here ow.ly/qVop50LJ3Es

Taking a new drug or medical device to market is always a long, unpredictable process, but clearing the final hurdle of regulatory approval remains a real challenge. Download our latest #eBook to learn more ow.ly/W2vL50LM4JI

Digital technologies have plenty to offer a #pharma industry seeking to up its productivity game. Discover how #AI and #MachineLearning can lead to more informed R&D and #BusinessDevelopment decisions here ow.ly/5TWm50LJ3Co

Want a quick overview of the happenings in the M&A landscape in Q3? Click here to download our free #infographic here ow.ly/LK5o50LyyC1

Just a few more hours until Dr Cem Baydar and Paul Verdin from #EvaluateLtd sit down with Treehill Partners to discuss the smart ways to get investment and deals moving as we head into 2023. Click here to register ow.ly/OOxW50LxNQg

What is holding things up and who might have to ‘blink’ first in making deals - #BigPharma or #biotech? Find out in our #webinar with #TreehillPartners on November 16th. Register here ow.ly/fw4550LxOlq

Were small #biotechs finally accepting the inevitable and taking deals they’d have laughed at a year ago? Find out in our Q3 report here. Download your copy today ow.ly/wECO50Lyyjg

What creative approaches are #dealmakers using to make deals more palatable for #bigpharma and #biotech? Find out on November 16th at 3 pm GMT (10 am EST) in our #webinar. Click here to register ow.ly/Z9Cr50LxNE8

It is time to look at what happened in Q3 with our snapshot #infographic. Get a quick overview of the M&A landscape to see that it is alive – but not kicking. Download your copy now ow.ly/qyei50Lyy1V

As 2023 approaches, #BigPharma and #biotech need to look at ways to get creative in a fundamentally strong but technically very volatile market. Join us on November 16th as we sit down with Treehill Partners to discuss more. Click here to register ow.ly/MHA150LxNcC

The $2.6bn acquisition of The Binding Site is 2022's biggest #medtech deal, but investors are unmoved. Read more about how #ThermoFisher flashes the #covid cash here ow.ly/Z3wA50LrHhF

Excellent networking dinner and reception last night at #BioEurope! Great atmosphere and good conversations. Looking forward to a final day of #networking and #partnering meetings. #BioEurope22 #BioEuroe2022 #lifesciences #pharma #biotech

Great first day at #BIOEurope yesterday! We're looking forward to more productive conversations and #networking. Connect with @evaluate via the #partnering platform. #BioEurope22 #lifesciences #pharma #biotech

Excellent opening session at #BioEurope on ‘Opportunities created by a bear market’ Interesting discussion on how to navigate the current market conditions. #BioEurope22 #lifesciences #pharma #biotech

@Evaluate has arrived at #BIOEurope! We look forward to seeing you all and a great few days of #networking with biotech and pharma leaders #BioEurope22 #lifesciences #pharma #biotech